Tepcomp is responsible for the manufacture of the new COVID-19 analyzer
The Finnish company Deep Sensing Algorithms Oy (DSA) has developed a unique DSA BreathPass™ device for testing COVID-19. The handheld analyser detects the Covid-19 virus from exhaled air and the diagnosis is established in seconds.
In the autumn of 2020, Tepcomp signed a cooperation agreement with DSA and will be responsible for the manufacture of the device. Manufacture of healthcare devices is the core competence of Tepcomp and the company has the ISO 13485 certificate required for the manufacture of medical devices.
“Tepcomp has many decades of experience and a good reputation in terms of healthcare equipment. The production of the BreathPass™ device involves demanding processes and sensitive technology, but we have full confidence in Tepcomp’s expertise and adherence to strict quality requirements,” says Pekka Rissanen, CEO of DSA.